πŸ‡ΊπŸ‡Έ FDA
Patent

US 11434293

Anti TRBC1 antigen binding domains

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11434293 (Anti TRBC1 antigen binding domains) held by AUTOLUS LIMITED expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/31